GSK’s jet-set scientist racks up travel bill worth nearly $800k


Glaxosmithline is under fire from shareholders over the “excessive” travel expenses of its chief scientist.

Hal Barron, the drugs giant’s highest-paid executive, received $807,000 (£620,000) in flights and hotels last year.

One major investor said that they were “taken aback” by the “monumentally high” expenses ahead of the company’s AGM next month.

Figures released by GSK show that Dr Barron, a high profile pharmacologist, last year racked up $464,000 worth of flights between his San Francisco home and GSK’s main research hubs in Philadelphia and Stevenage.